8 Dividend Stocks Every Investor Should Consider

The piece highlights eight dividend-focused stocks that balance current income and long-term compounding, citing yields and payout ratios as key selection criteria: American Express (yield 0.87%, payout ratio 16%), JPMorgan (2% yield, 28% payout), Costco (0.5% yield, 27% payout, $15 special dividend in 2023), S&P Global (0.8% yield, 28% payout, 52 years of raises), AbbVie (3% yield, 53-year raise streak), Pfizer (6.7% yield, ~98% payout ratio), Philip Morris (3.8% yield, ~78% payout) and Nvidia (0.02% yield, 1% payout ratio, quarterly revenue >$35bn). The article emphasizes diversified income sources—from high-yield pharma and tobacco to low-yield growth compounders and AI-driven secular winners—calling out payout sustainability, special dividends, and growth drivers (pipelines, smoke-free products, AI GPUs) that matter for long-term dividend portfolios.

Analysis

Market structure: Winners are durable, cash-generative franchises (SPGI, AXP, COST, NVDA) that can compound dividends or repurchase stock; losers are high payout, earnings-sensitive names (PFE, PM) if revenue or margins slip. Expect price-insensitive recurring‑revenue assets (ratings, memberships) to tighten valuation spreads vs cyclicals over 6–24 months, while AI-driven free cash flow (NVDA) re-rates growth multiples and compresses yield premium demanded by income buyers.

Risk assessment: Tail risks include regulatory action (tobacco/FDA, pharma pricing suits), biotech pipeline failures (ABBV), and abrupt AI demand normalization that trims NVDA revenue — each could meaningfully move payouts or buybacks within 1–12 months. Hidden dependencies: Costco and AXP rely on consumer discretionary strength and affluent spending; a 2–3% GDP slowdown would proportionally pressure merchant volumes and special dividends.

Trade implications: Tactical: overweight SPGI and NVDA for 12–36 months (compounding + secular AI), underweight/hedge PFE and PM where payout ratios exceed sustainable thresholds (PFE ~98%, PM ~78%). Use pairs: long SPGI vs short PFE to capture quality spread compression; implement options collars on PFE holdings to protect dividend income over the next 6 months.

Contrarian angles: Consensus prizes headline yields; it underestimates the opportunity cost of owning high-yield but unstable payers — PFE’s yield is likely pricing a >25% chance of dividend pressure within 12 months. Conversely, market underweights “stealth dividend” growers (NVDA, AXP) whose 5‑year total‑return if reinvested could outpace static 3–7% yields; mispricings will surface on macro shocks or earnings beats.

Key Decisions for Investors

• Establish a 1.5–2.5% long position in NVDA (core growth/dividend compounding) using scaled buys: add on any single-session drop >10% within next 3 months; hedge with 9–12 month OTM (10% OTM) puts sized 25% of position if implied vol spikes above historical 6‑month mean.
• Initiate a 1.5% long position in SPGI and fund an equal-size short position in PFE (pair trade) to capture quality vs income-risk spread; rebalance quarterly and trim short PFE if its dividend coverage ratio improves to <90% payout within two consecutive quarters.
• Reduce direct exposure to PM and other tobacco names by 50% from benchmark weight over 30 days; redeploy proceeds into ABBV (target 1–2% allocation) for >=3% yield with pipeline optionality, trimming ABBV if guidance misses by >5% on next quarter.
• For income sleeve holders of PFE, implement a protective collar for 6 months: sell 10% OTM covered calls and buy 10% OTM puts (roll as needed) to preserve ~6–8% yield while capping downside at ~10–12% over the collar term; exit if PFE announces sustainable dividend policy (coverage >120%) or cuts dividend.